Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors

被引:28
|
作者
Zarghi, Afshin [1 ]
Kakhgi, Samaneh [1 ]
Hadipoor, Atefeh [1 ]
Daraee, Bahram [2 ]
Dadrass, Orkideh G. [3 ]
Hedayati, Mehdi [4 ]
机构
[1] Shahid Beheshti Univ Med Sci, Dept Pharmaceut Chem, Sch Pharm, Tehran, Iran
[2] Tarbiat Modares Univ, Tehran, Iran
[3] Azad Univ, Sch Pharm, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Tehran, Iran
关键词
1,3-diarylurea; COX-2; inhibition; SAR;
D O I
10.1016/j.bmcl.2008.01.021
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A group of 1,3-diarylurea derivatives, possessing a methylsulfonyl pharmacophore at the para-position of the N-1 phenyl ring, in conjunction with a N-3 substituted-phenyl ring (4-F, 4-Cl, 4-Me, 4-OMe), were designed and synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. In vitro COX-1/COX-2 isozyme inhibition structure - activity studies identified 1-(4methylsulfonylphenyl)-3-(4- methoxyphenyl) urea (4e) as a potent COX-2 inhibitor (IC50 = 0.11 mu M) with a high COX-2 selectivity index ( SI = 203.6) comparable to the reference drug celecoxib (COX-2 IC50 = 0.06 mu M; COX-2 SI =405). The structure - activity data acquired indicate that the urea moiety constitutes a suitable scaffold to design new acyclic 1,3-diarylurea derivatives with selective COX-2 inhibitory activity. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1336 / 1339
页数:4
相关论文
共 50 条
  • [31] Synthesis and biological evaluation of resveratrol amide derivatives as selective COX-2 inhibitors
    Xin, Min
    Wu, Haoyu
    Du, Yuan
    Liu, Sheng
    Zhao, Feng
    Mou, Xiaofeng
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 380
  • [32] Synthesis and biological evaluation of ester derivatives of indomethacin as selective COX-2 inhibitors
    Babu, M. Arockia
    Shukla, Rakesh
    Nath, Chandishwar
    Kaskhedikar, S. G.
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (09) : 2223 - 2228
  • [33] Design, synthesis and biological evaluation of chalcone derivatives possessing a methanesulfonamido pharmacophore as selective COX-2 inhibitors
    Zebardast, T.
    Zarghi, A.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 : A48 - A49
  • [34] Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors
    Kulkarni, SK
    Jain, NK
    Singh, A
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2000, 22 (05): : 291 - 298
  • [35] Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis
    Watson, DJ
    Harper, SE
    Zhao, PL
    Quan, H
    Bolognese, JA
    Simon, TJ
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (19) : 2998 - 3003
  • [36] New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity
    Farzaneh, Shabnam
    Zeinalzadeh, Elnaz
    Daraei, Bahram
    Shahhosseini, Soraya
    Zarghi, Afshin
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (02) : 295 - 301
  • [37] Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk
    Ashok, Varun
    Dash, Chiranjeev
    Rohan, Thomas E.
    Sprafka, J. Michael
    Terry, Paul D.
    BREAST, 2011, 20 (01): : 66 - 70
  • [38] Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors
    Abdellatif, Khaled R. A.
    Abdelgawad, Mohamed A.
    Labib, Madlen B.
    Zidan, Taha H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (24) : 5787 - 5791
  • [39] Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer
    Kundu, N
    Fulton, AM
    CANCER RESEARCH, 2002, 62 (08) : 2343 - 2346
  • [40] Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers in rats
    Konturek, SJ
    Sliwowski, Z
    Brzozowski, T
    Konturek, PC
    Pajdo, R
    Drozdowicz, D
    Stachura, J
    Hahn, EG
    GASTROENTEROLOGY, 1999, 116 (04) : A220 - A220